Sign up for our newsletter

Below is a report that DML News gives a 4 OUT OF 4 STARS trustworthiness rating. We base this rating on the following criteria:

  • Provides named sources
  • Reported by more than one notable outlet
  • Does not insert opinion or leading words
  • Includes supporting video, direct statements, or photos

Click here to read more about our rating system.

As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by NYPost.com:

The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The article goes on to state the following:

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

To get more information about this article, please visit NYPost.com.

Sign up for our newsletter
Previous articleTexas Voter: ‘We Will Never Give Up’
Next articleWATCH: Trump supporters hold MASSIVE “Stop The Steal” rally in Georgia

2 COMMENTS

  1. Those bodies in El Paso are illegals coming here from south America.
    They come here sick and die. They would have died anywhere they were.
    I wouldn’t put it past their own governments or other perpetrators there to inject them hoping to infect more Americans.
    It’s not the fault of our state or local government.

LEAVE A REPLY

Please enter your comment!
Please enter your name here